Expected...In Q2 CY 2016 Teva and Mesoblast to provide updated timelines for completion of current reduced Phase 3 Trial, regulatory submissions, and overall program completion... .another version....During Q2 CY 2016: – European sites will be initiated for current Phase 3 trial – Updated timelines will be provided for completion of the current Phase 3 trial, FDA and EMA regulatory submissions, and overall program completion, including a confirmatory trial............Also .....The main candidate of licensing is MPC-06-ID for chronic low back pain (CLBP), as a result of degenerative disc disease. While not contained in the company’s releases, the clear impression from the presentation was that a deal for MPC-06-ID would be done this quarter or next (Q1 FY17)...........SI words were " in a short term"..To me the short term is up to 3-4 weeks thats a guess ..There is much happening with many apps .nothing would surprise ! V
- Forums
- ASX - By Stock
- MSB
- Some are positive !!
Some are positive !!, page-28
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.13 |
Change
-0.055(4.66%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.18 | $1.18 | $1.13 | $4.824M | 4.236M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25589 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25589 | 1.125 |
16 | 303483 | 1.120 |
2 | 136703 | 1.115 |
9 | 203201 | 1.110 |
3 | 61500 | 1.105 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 10000 | 1 |
1.135 | 20000 | 1 |
1.140 | 60630 | 4 |
1.145 | 29630 | 2 |
1.150 | 93731 | 8 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |